<DOC>
	<DOCNO>NCT01401088</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety Aurolab Artificial Drainage Implant ( AADI ) intraocular pressure reduction patient refractory glaucoma .</brief_summary>
	<brief_title>Evaluation Safety Efficacy Glaucoma Shunt ( Aurolab Artificial Drainage Implant ) Refractory Glaucoma</brief_title>
	<detailed_description>Aurolab Artificial Drainage Implant non resistant tube device base Baerveldt implant . It reduce intra ocular pressure drain aqueous anterior chamber sub-conjunctival space form around base implant . Reduction intraocular pressure prevents damage optic nerve functional visual field loss advance refractory glaucoma .</detailed_description>
	<mesh_term>Glaucoma</mesh_term>
	<criteria>18 year age old Significant optic nerve damage visual field loss due glaucoma eligible eye Eligible eye consider high risk failure/complication follow conventional filter surgery Eyes uncontrolled glaucoma prior history Filtering surgery/Uveitic/ Neovascular/Developmental glaucoma IOPâ‰¥18 mm Hg without anti glaucoma medication If take glaucoma medication , stable dose 6 week Age &lt; 18 year Eyes uncontrolled glaucoma expect favorable postoperative outcome conventional trabeculectomy Corneal abnormality would preclude accurate IOP reading Uncontrolled systemic disease Endothelial cell count &lt; 1800cells/mm Any active ocular disease , ( active uveitis , ocular infection )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>patient refractory glaucoma</keyword>
</DOC>